40th Congress of the Société Internationale d'Urologie

SIU
America/New York GMT -4 summer

Description

0100-0115

 

PL-00: Welcome Message

 

Honorary Chairs: Christopher Evans, United States / Sanjay Kulkarni, India / Rajeev Kumar, India

To view this session in your own timezone, please click here.

 

0115-0120

 

PL-00: Award Ceremony

 

Honorary Chair: Reynaldo Gómez, Chile

To view this session in your own timezone, please click here.

 

0130-0215

 

PL-01: Plenary-Asia/Oceania

 

To view this session in your own timezone, please click here.

 

0130-0145

Urological Association of Asia (UAA) Lecture: Management of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients

Kyu-Sung Lee, South Korea

 

0145-0215

Joint SIU-ICUD/WUOF Molecular Biomarkers in Genitourinary Cancers

 

Chair: Laurence Klotz, Canada

Faculty

Nathan Lawrentschuk, Australia

Yair Lotan, United States

Jack Schalken, The Netherlands

 

0230-0300

 

SYMP-01: Urological Association of Asia (UAA) Symposium

 

Co-Chairs: Allen W. Chiu, Taiwan / Chun-Te Wu, Taiwan

To view this session in your own timezone, please click here.

 

0230-0230

Current Status of Robotic Urological Surgery (RUS) in Asia

Gyung Tak Sung, South Korea

 

0240-0250

Evolving Novel Robotic Technology in Urology

Chun-Te Wu, Taiwan

 

0250-0300

Advanced Information Network and Artificial Intelligence - Relationship with Robotic Surgery

Allen W. Chiu, Taiwan

 

0300-0400

 

CO-01: Controversies in Urology 01 - New Challenges in Imaging and Management of Oligometastatic Prostate Cancer

 

Co-Chairs: Prasanna Sooriakumaran, United Kingdom / Derya Tilki, Germany/United States

To view this session in your own timezone, please click here.

 

 

At the end of this session, attendees will be able to:

 

Learn about controversies in the definition of oligometastatic prostate cancer and standard and novel imaging modalities to define it.

Recall treatment options in the management of oligometastatic prostate

cancer and current controversies in choice of management.

Understand current best practice data and learn about emerging clinical trials in oligometastatic prostate cancer.

 

0300-0305

Introduction

Derya Tilki, Germany/United States

 

0305-0330

DEBATE 1: Imaging in the Definition of Oligometastatic Prostate Cancer

 

0305-0315

Oligometastatic Disease Should Be Defined Based on Standard Imaging Modalities

Noel Clarke, United Kingdom

 

0315-0325

Oligometastatic Disease Should Be Defined Based on Novel Imaging Modalities

Renu Eapen, Australia

 

0325-0330

Discussion

 

0330-0350

DEBATE 2: Management of the Metastases in Oligometastatic Prostate Cancer

 

0330-0340

The Metastases Should be Treated with Metastasis-Directed Therapy

Patrick Cheung, Canada

 

0340-0350

The Metastases Should be Treated with Best Systemic Therapy Alone

Noel Clarke, United Kingdom

 

0350-0400

Summary

Prasanna Sooriakumaran, United Kingdom

 

0300-0400

 

 

JS-01: Joint SIU-International Society of Reconstructive Urology (ISORU)/Society of Genitourinary Reconstructive Surgeons (GURS) Session

 

Co-Chairs: Sanjay Kulkarni, India / Jeremy Myers, United States

To view this session in your own timezone, please click here.

 

 

Learning Objectives

 

At the end of this session, attendees will be able to:

 

Describe the potential advantages of Non-transecting bulbar urethroplasty in regards to preservation of bulbar arterial flow and preservation of erectile function.

Outcomes of ventral placement of buccal graft for fossa navicularis strictures and the technique for this surgery.

Describe various approaches for salvage hypospadias repair in adults and how to approach primary hypospadias repair in adults. Contrast differences in adult surgery versus children.

Method: Lectures and discussion

 

0300-0310

Non-Transecting Bulbar Urethroplasty Technique

Daniela Andrich, United Kingdom

 

0310-0320

Ventral Buccal Graft for Fossa Navicularis Strictures

Dmitriy Nikolavsky, United States

 

0320-0330

Q&A

 

Moderators

Justin Chee, Australia

Sanjay Kulkarni, India

Jeremy Myers, United States

 

0330-0340

Salvage Hypospadias Repair in Adults

Pankaj Joshi, India

 

0340-0350

Primary Hypospadias Repair in Adults

Marta Bizic, Serbia

 

0350-0400

Q&A

 

Moderators

Jill Buckley, United States

Andre Cavalcanti, Brazil

Francisco E. Martins, Portugal

 

0400-0430

 

SYMP-02: Joint SIU-Chinese Urological Association (CUA) Symposium

 

Chair: Li-Ping Xie, China

To view this session in your own timezone, please click here.

 

 

0430-0500

 

SYMP-03: Joint SIU-Korean Urological Association (KUA) Symposium

 

Chair: Kyu-Sung Lee, South Korea

To view this session in your own timezone, please click here.

 

0430-0432

Welcome Address by KUA President

Kyu-Sung Lee, South Korea

 

0432-0437

Expanded Use of Flexible Ureteroscope: What's New?

Sung Yong Cho, South Korea

 

0437-0442

What is Optimal Treatment for Long Segment Urethral Stricture?

Arun Chawla, India

 

0442-0447

How to Overcome 5ARI-Induced Erectile Dysfunction (ED)

Sun Tae Ahn, South Korea

 

0447-0452

Role of Ureteroscopy Before Radical Nephroureterectomy: Advantages and Limitations

Paolo Gontero, Italy

 

0452-0457

Management of Non-Metastatic CRPC: Lesson From Recent Landscape Trial

ByungHoon Kim, South Korea

 

0457-0500

Closing Remarks by SIU President

Sanjay Kulkarni, India

 

0500-0600

 

PL-02: Plenary-Europe/Africa

 

To view this session in your own timezone, please click here.

 

0500-0515

European Association of Urology Lecture: Adoption of New Techniques for the Treatment of Benign Prostatic Obstruction: What Are the Requirements?

Stavros Gravas, Greece

 

0515-0530

Pan African Urological Surgeons Association Lecture: Reconstructive Urology for Complex Obstetrics Fistulae

Serigne Magueye Gueye, Senegal

 

0530-0545

Burnout in Urological Training

Tobias Kohler, United States

 

0545-0600

HIV and Circumcision

Timothy Hargreave, United Kingdom

 

0600-0700

 

IC-01: Instructional Course 01 - Lower Urinary Tract Symptoms and Urinary Tract Infections in Children

 

Chair: M. Ihsan Karaman, Turkey

To view this session in your own timezone, please click here.

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Understand diagnosis and management of basic and complicated urological infections in children

Describe the current management of lower urinary tract dysfunction with or without UTI in children

Have an overview on common pediatric urological conditions of the urinary tract

Have a general idea about medical, minimally invasive and surgical management of pediatric lower urinary tract dysfunction and infections

Manage some of the common pediatric urological diseases medically

 

0600-0610

Urotherapy: An Underrecognized Valuable Tool for Daytime LUTS

Walid Farhat, United States

 

0610-0620

Botulinum Toxin Injection for Non-neurogenic Bladder in Children

Sean Corbett, United States

 

0620-0630

Daytime LUTS and Urinary Infections, How to Break the Cycle?

Walid Farhat, United States

 

0630-0640

Antibiotic Prophylaxis for Antenatal Hydronephrosis

Tarkan Soygur, Turkey

 

0640-0650

Update on Antibiotic Prophylaxis in Children with Vesicoureteral Reflux

Sean Corbett, United States

 

0650-0700

How to Deal with Recurrent UTI in Augmented Bladders in Children

Tarkan Soygur, Turkey

 

0700-0800

 

IC-02: Instructional Course 02 - Gender Affirmation Surgery: Role of the Urologist

 

Chair: Miroslav Djordjevic, Serbia

To view this session in your own timezone, please click here.

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Define the role of urologist in gender affirmation surgery.

Report the recent surgical modalities in both, male to female and female to male gender affirming surgery.

Recognize most important surgical steps in male-to-female and female-to-male gender affirmation surgery; define and achieve successful outcome.

Summarize possible postoperative complications

Conduct postoperative urethral problems in transmen and present the options for correction

Recognize urological complications after male to female transgender surgery and describe the current management

 

0700-0710

Introduction by Urologist

Miroslav Djordjevic, Serbia

 

0710-0725

Metoidioplasty: Clitoral Dissection, Urethroplasty, Outcomes

Marta Bizic, Serbia

 

0725-0740

Phalloplasty: View from Urologist

Daniel Dugi, United States

 

0740-0755

Vaginoplasty: Techniques, Outcomes and Complications

 

Rajveer Purohit, United States

0755-0800

 

Discussion

 

0800-0900

 

MC-01: Master Class 01 - Hypospadias Surgery for the General Urologist

 

Co-Chairs: Rados Djinovic, Serbia / Joao Luiz Pippi Salle, Qatar

Moderator: Aseem Shukla, United States

To view this session in your own timezone, please click here.

 

Learning Objectives:

 

At the conclusion of this activity, participants will be able to:

 

Present and discuss the main anatomic characteristics that influence the decision for technical repairs

Elaborate the rationale for pre‐operative use of hormone stimulation and peri‐operative antibiotic prophylaxis

Present technical details for repair of primary as well as redo hypospadias, including utilization of videos

Promote ample discussion about follow up as well as the main post op complications

Comment on possible differences for treatment of hypospadias in children and in the post pubertal period

 

0800-0915

 

SYMP-04: Symposium: Multidisciplinary Management of Early Stage Bladder Cancer

 

Chair: Peter Black, Canada

To view this session in your own timezone, please click here.

 

 

Learning Objectives

 

At the end of this session, attendees will be able to:

• Review the most updated guidelines on NMBIC and MIBC

• Recognize the importance of risk stratification in the treatment decision-making for NMIBC and MIBC

• Review potential biomarkers to predict response to chemotherapy and immunotherapy in MIBC

• Analyze key data from clinical trials of IO and novel therapies in NMIBC, as well as emerging and combination therapies for MIBC

• Recognize the importance of a multidisciplinary team-based care planning for patients with early stage disease

• Outline immune-related adverse events and best practices for their mitigation and management

 

 

Faculty

 

Jürgen Gschwend, Germany

Shilpa Gupta, United States

Srikala Sridhar, Canada

Tilman Todenhöfer, Germany

 

0930-1045

 

PL-03: Plenary-Americas

 

To view this session in your own timezone, please click here.

 

0930-0945

Canadian Urological Association Lecture: The Current and Future State of Robotics in Oncology

Robert Hamilton, Canada

 

0945-1000

State of the Art Lecture: Gender Issues in Urology

Maria J. Ribal, Spain

 

1000-1015

Confederación Americana de Urología Lecture: Management of Double Collecting System Pathology in Children

Juan Prieto, United States

 

1015-1030

American Urological Association Lecture: The Future of Surgery for Advanced Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors

E. Jason Abel, United States

 

1100-1145

 

MC-03: Master Class 03 - New Technologies in Stone Removal

 

Co-Chairs: Petrisor Aurelian Geavlete, Romania / Amy Krambeck, United States

To view this session in your own timezone, please click here.

 

 

Learning Objectives:

 

Describe and determine the proper laser settings for different type of stone fragmentation approaches for ureteroscopic stone removal

Evaluate the benefits and limitations of the different devices currently available for percutaneous stone removal

Describe the current accepted approaches and new approaches to percutaneous stone access

Determine the appropriate use of different types of ureteral access, scopes and stone retrieval devices for ureteroscopic stone removal

Methods to promote active learning:

 

Didactic lectures with time allotted for questions from the audience

Course directors will facilitate questions from the audience and encourage participation

An interactive audience participation case presentation will occur after the didactic lectures. The cases will focus on all the material presented during the lectures.

 

1100-1105

Introduction

Petrisor Aurelian Geavlete, Romania

 

1105-1115

Advancements in Percutaneous Renal Access

Bodo E. Knudsen, United States

 

1115-1125

Devices for Percutaneous Stone Removal

Amy Krambeck, United States

 

1125-1135

Current Ureteroscopes and Stone Removal Devices

Ismael Sedano Portillo, Mexico

 

1135-1145

Laser Technologies and Settings in Renal Stones

Petrisor Aurelian Geavlete, Romania

 

1100-1200

 

IC-03: Instructional Course 03 - Lymphadenectomy in Urologic Cancer

 

Co-Chairs: Sia Daneshmand, United States / George Thalmann, Switzerland

To view this session in your own timezone, please click here.

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Identify patients in need of lymphadenectomy in urological cancers

Apply the correct template for lymphadenectomy and their extension

Recognize the techniques used and potential complications of lymphadenectomy in urological cancers

 

1100-1110

Is Lymphadenectomy Necessary in Prostate Cancer? Pros and Cons

Alberto Briganti, Italy

 

1110-1120

Lymphadenectomy for Urothelial Cancer: How Far to Go? Bladder and Upper Tract

George Thalmann, Switzerland

 

1120-1130

Renal Cell Cancer: Does Lymphadenectomy Make a Difference? And When?

Faculty: Axel Bex, The Netherlands

 

1130-1140

Penile Cancer: When and Which Template?

Curtis Pettaway, United States

 

1140-1150

Retroperitoneal Llymphadenectomy In Testicular Cancer: What Are the Challenges Today? Indications and Extent

Sia Daneshmand, United States

 

1150-1200

Q&A and Discussion

Sia Daneshmand, United States

 

1145-1300

 

SYMP-05: Symposium: Up Close and Personal: Talking to your Patients about Overactive Bladder

 

Chair: Lysanne Campeau, Canada

To view this session in your own timezone, please click here.

 

 

Learning Objectives

 

At the end of this session, attendees will be able to:

• Review the recommended guidelines for the diagnosis and treatment of OAB

• Discuss complications of diagnosis due to common comorbid conditions

• Compare and contrast the different pharmacologic therapies in terms of their efficacy and tolerability for the management of OAB

• Propose strategies for a more personalized approach to behavioral and pharmacological therapies to ensure efficacy and treatment adherence

• Describe follow-up strategies and making necessary modifications to the therapeutic plan to optimize efficacy, promote adherence, and minimize side effects

 

 

Faculty

 

Dean Elterman, Canada

Stavros Gravas, Greece

Sender Herschorn, Canada

 

1300-1400

 

SYMP-06: World Urologic Oncology Federation (WUOF) Symposium

 

Co-Chairs: Peter Hammerer, Germany / Laurence Klotz, Canada

To view this session in your own timezone, please click here.

 

1300-1301

Welcome and Introductions

Chair: Laurence Klotz, Canada

 

1301-1319

Should mpMRI Be the Male Mammogram?

Sigrid V. Carlsson, United States

 

1319-1337

Proteogenomics and Predicting Response to Chemotherapy

Seth Lerner, United States

 

1337-1400

A Preclinical Strategy for Better Predicting Therapeutic Outcomes in the Clinic: Kidney and Breast Cancers as Paradigms’

Robert Kerbel, Canada

 

1400-1410

 

01: Keynote Speaker

 

To view this session in your own timezone, please click here.

 

 

Never Give Up!

Ivan Loredo Vidal, Mexico

 

1900-2000

 

MC-02: Master Class 02 - Genomic Testing and Recurrence in Prostate Cancer

 

Co-Chairs: Shusuke Akamatsu, Japan / Marc Dall'Era, United States

To view this session in your own timezone, please click here.

 

Learning Objectives

 

Recognize when to order genomic testing in prostate cancer treatment

Determine who is expected to benefit from treatment with PARP inhibitors

Explain the importance of genetic counseling

State the current status and future prospect of liquid biopsy

 

1900-1912

 

The Role of Genomic Testing in Prostate Cancer

Vito Cucchiara, Italy

 

1912-1924

DNA Repair Gene Mutations and PARP Inhibitors in Prostate Cancer

Marc Dall'Era, United States

 

1924-1936

Genetic Counselling in Prostate Cancer

Scott Eggener, United States

 

1936-1948

Liquid Biopsy in Prostate Cancer, Where Are We Now?

Shusuke Akamatsu, Japan

 

1948-2000

Debate and Q&A on Availability of Genetic Testing and Counselling in Each Region (United States, Italy, and Japan)

Shusuke Akamatsu, Japan

Vito Cucchiara, Italy

Marc Dall'Era, United States

Scott Eggener, United States

Christopher Evans, Sanjay Kulkarni, Rajeev Kumar, Reynaldo Gómez, Allen W. Chiu, Chun-Te Wu, Prasanna Sooriakumaran, Derya Tilki, Jeremy Myers, Li-Ping Xie, Kyu-Sung Lee, M. Ihsan Karaman, Miroslav Djordjevic, Rados Djinovic, Joao Luiz Pippi Salle, Aseem Shukla, Peter Black, Petrisor Aurelian Geavlete, Amy Krambeck, Sia Daneshmand, George Thalmann, Lysanne Campeau, Peter Hammerer, Laurence Klotz, Shusuke Akamatsu, Marc Dall'Era

PL-00: Welcome Message, PL-00: Award Ceremony, PL-01: Plenary-Asia/Oceania, SYMP-01: Urological Association of Asia (UAA) Symposium, CO-01: Controversies in Urology 01 - New Challenges in Imaging and Management of Oligometastatic Prostate Cancer, JS-01: Joint SIU-International Society of Reconstructive Urology (ISORU)/Society of Genitourinary Reconstructive Surgeons (GURS) Session, SYMP-02: Joint SIU-Chinese Urological Association (CUA) Symposium, SYMP-03: Joint SIU-Korean Urological Association (KUA) Symposium, PL-02: Plenary-Europe/Africa, IC-01: Instructional Course 01 - Lower Urinary Tract Symptoms and Urinary Tract Infections in Children, IC-02: Instructional Course 02 - Gender Affirmation Surgery: Role of the Urologist, MC-01: Master Class 01 - Hypospadias Surgery for the General Urologist, SYMP-04: Symposium: Multidisciplinary Management of Early Stage Bladder Cancer, PL-03: Plenary-Americas, MC-03: Master Class 03 - New Technologies in Stone Removal, IC-03: Instructional Course 03 - Lymphadenectomy in Urologic Cancer, SYMP-05: Symposium: Up Close and Personal: Talking to your Patients about Overactive Bladder, SYMP-06: World Urologic Oncology Federation (WUOF) Symposium, 01: Keynote Speaker, MC-02: Master Class 02 - Genomic Testing and Recurrence in Prostate Cancer

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Kyu-Sung Lee, Nathan Lawrentschuk, Yair Lotan, Jack Schalken, Gyung Tak Sung, Chun-Te Wu, Allen W. Chiu, Derya Tilki, Noel Clarke, Renu Eapen, Patrick Cheung, Prasanna Sooriakumaran, Daniela Andrich, Dmitriy Nikolavsky, Pankaj Joshi, Marta Bizic, Kyu-Sung Lee, Sung Yong Cho, Arun Chawla, Sun Tae Ahn, Paolo Gontero, ByungHoon Kim, Stavros Gravas, Serigne Magueye Gueye, Tobias Kohler, Timothy Hargreave, Walid Farhat, Sean Corbett, Tarkan Soygur, Miroslav Djordjevic, Marta Bizic, Daniel Dugi, Rajveer Purohit, Jürgen Gschwend, Shilpa Gupta, Srikala Sridhar, Tilman Todenhöfer, Robert Hamilton, Maria J. Ribal, Juan Prieto, E. Jason Abel, Petrisor Aurelian Geavlete, Bodo E. Knudsen, Amy Krambeck, Ismael Sedano Portillo, Petrisor Aurelian Geavlete, Alberto Briganti, George Thalmann, Axel Bex, Curtis Pettaway, Sia Daneshmand, Dean Elterman, Stavros Gravas, Sender Herschorn, Sigrid V. Carlsson, Seth Lerner, Robert Kerbel, Ivan Loredo Vidal, Vito Cucchiara, Marc Dall'Era, Scott Eggener, Shusuke Akamatsu

 

Link to the Event

Banner to the Event

40th Congress of the Société Internationale d'Urologie
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2020 "24 years inspiring technology"